November 12, 2012
The Ministry of Health, Labor and Welfare (MHLW) has chosen zoledronic acid (original product: the bone resorption inhibitor Zometa) and sildenafil (the erectile dysfunction (ED) treatment Viagra) as active pharmaceutical ingredients (APIs) subject to a planned pilot study for the...read more